Mucinex and Jakafi drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Mucinex and Jakafi together. This review analyzes the effectiveness and drug interactions between Mucinex and Jakafi. It is created by eHealthMe based on reports of 46 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Mucinex and Jakafi, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Mucinex and Jakafi

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 11,124 users)

Jakafi

Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. (latest outcomes from Jakafi 9,384 users)

On Jan, 23, 2017

46 people who take Mucinex, Jakafi are studied.


Number of reports submitted per year:

Mucinex and Jakafi drug interactions.

Most common drug interactions over time *:

< 1 month:
  • lymphoma
  • platelet count increased
1 - 6 months:
  • anaemia
  • contusion
  • disease progression
  • leukocytosis
  • pancytopenia
  • performance status decreased
  • thrombocytopenia
  • cardiac failure
  • depressed mood
  • drug ineffective
6 - 12 months:
  • anaemia
  • asthenia
  • thrombocytopenia
  • urinary tract infection
  • abdominal pain
  • chills
  • colitis
  • confusional state
  • decreased appetite
  • dehydration
1 - 2 years:
  • lung cancer metastatic
  • pneumonia
  • renal failure acute
  • deep vein thrombosis
  • hypovolaemia
2 - 5 years:
  • abdominal pain
  • bone pain
  • bronchitis
  • contusion
  • fatigue
  • lymphoma
  • red blood cell count decreased
  • splenomegaly
not specified:
  • fatigue
  • splenomegaly
  • dyspnoea
  • pulmonary hypertension
  • abdominal pain
  • anaemia
  • pneumonia
  • platelet count decreased
  • cardiac failure congestive
  • ecchymosis

Most common drug interactions by gender *:

female:
  • abdominal pain
  • fatigue
  • platelet count decreased
  • dyspnoea
  • pain in extremity
  • pneumonia
  • anaemia
  • contusion
  • splenomegaly
  • cardiac failure
male:
  • cardiac failure congestive
  • fatigue
  • pulmonary hypertension
  • rash
  • splenomegaly
  • anaemia
  • dyspnoea
  • cellulitis
  • decreased appetite
  • ecchymosis

Most common drug interactions by age *:

40-49:
  • abdominal distension
  • contusion
  • fluid retention
  • headache
  • hunger
  • joint swelling
  • pain in extremity
  • platelet count decreased
  • weight increased
50-59:
  • anxiety
  • depression
  • discomfort
  • dysstasia
  • fatigue
  • flatulence
  • haematocrit decreased
  • haemoglobin decreased
  • inflammation
  • pain
60+:
  • dyspnoea
  • pneumonia
  • pulmonary hypertension
  • fatigue
  • anaemia
  • splenomegaly
  • platelet count decreased
  • decreased appetite
  • musculoskeletal pain
  • cardiac failure

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Mucinex and Jakafi?

Interactions between Mucinex and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Jakafi and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Mucinex (guaifenesin) is often used to treat cough. Jakafi (ruxolitinib phosphate) is often used to treat primary myelofibrosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Mucinex, Jakafi

You may be interested in these reviews

More reviews for: Mucinex, Jakafi